Skip to main content

Advertisement

Log in

2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine

A new potent anticancer drug

  • Original Articles
  • 2,4-Diamino-6-(Bis-2-Chioroethyl)Aminomethyl Pteridine
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine has been synthesized and found to be highly potent against L-1210 mouse leukemia lymphoblasts. A single dose of 5 mg/kg injected 24 h after the tumor inoculation increased the life-span of 50% of mice to more than 200%, while the other 505 of animals were cured.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Calabresi P, Parks RE Jr (1980) Chemotherapy of neoplastic disease. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan, New York, pp 1249–1313

    Google Scholar 

  2. Khaled MA, Benington E, Morin RD (1984) Patent applications covering this compound and its analogs and homologs have been filed through Research Corporation of USA

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khaled, M.A., Morin, R.D., Benington, F. et al. 2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine. Cancer Chemother. Pharmacol. 13, 73–74 (1984). https://doi.org/10.1007/BF00257116

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00257116

Keywords

Navigation